These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 9410908)
1. Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis. Kerjaschki D; Exner M; Ullrich R; Susani M; Curtiss LK; Witztum JL; Farquhar MG; Orlando RA J Clin Invest; 1997 Nov; 100(9):2303-9. PubMed ID: 9410908 [TBL] [Abstract][Full Text] [Related]
2. Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane. Kerjaschki D; Miettinen A; Farquhar MG J Exp Med; 1987 Jul; 166(1):109-28. PubMed ID: 2885390 [TBL] [Abstract][Full Text] [Related]
3. Mapping rat megalin: the second cluster of ligand binding repeats contains a 46-amino acid pathogenic epitope involved in the formation of immune deposits in Heymann nephritis. Saito A; Yamazaki H; Rader K; Nakatani A; Ullrich R; Kerjaschki D; Orlando RA; Farquhar MG Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8601-5. PubMed ID: 8710917 [TBL] [Abstract][Full Text] [Related]
4. Megalin (gp330) possesses an antigenic epitope capable of inducing passive Heymann nephritis independent of the nephritogenic epitope in receptor-associated protein. Orlando RA; Kerjaschki D; Farquhar MG J Am Soc Nephrol; 1995 Jul; 6(1):61-7. PubMed ID: 7579071 [TBL] [Abstract][Full Text] [Related]
5. The Heymann nephritis antigenic complex: megalin (gp330) and RAP. Farquhar MG; Saito A; Kerjaschki D; Orlando RA J Am Soc Nephrol; 1995 Jul; 6(1):35-47. PubMed ID: 7579068 [TBL] [Abstract][Full Text] [Related]
6. Molecular cloning of a cDNA encoding a major pathogenic domain of the Heymann nephritis antigen gp330. Pietromonaco S; Kerjaschki D; Binder S; Ullrich R; Farquhar MG Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1811-5. PubMed ID: 2408041 [TBL] [Abstract][Full Text] [Related]
7. Induction of passive Heymann nephritis with antibodies specific for a synthetic peptide derived from the receptor-associated protein. Kerjaschki D; Ullrich R; Exner M; Orlando RA; Farquhar MG J Exp Med; 1996 May; 183(5):2007-15. PubMed ID: 8642311 [TBL] [Abstract][Full Text] [Related]
8. Induction of Heymann nephritis with a gp330/megalin fusion protein. Raychowdhury R; Zheng G; Brown D; McCluskey RT Am J Pathol; 1996 May; 148(5):1613-23. PubMed ID: 8623929 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis. Susani M; Schulze M; Exner M; Kerjaschki D Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779 [TBL] [Abstract][Full Text] [Related]
10. All four putative ligand-binding domains in megalin contain pathogenic epitopes capable of inducing passive Heymann nephritis. Yamazaki H; Ullrich R; Exner M; Saito A; Orlando RA; Kerjaschki D; Farquhar MG J Am Soc Nephrol; 1998 Sep; 9(9):1638-44. PubMed ID: 9727372 [TBL] [Abstract][Full Text] [Related]
11. Metabolic fate of monovalent and multivalent antibodies of Heymann nephritis following formation of surface immune complexes on glomerular epithelial cells. Singh AK; Kasinath BS Clin Exp Immunol; 1993 Dec; 94(3):403-11. PubMed ID: 8252800 [TBL] [Abstract][Full Text] [Related]
12. Truncated apo B-70.5-containing lipoproteins bind to megalin but not the LDL receptor. Chen Z; Saffitz JE; Latour MA; Schonfeld G J Clin Invest; 1999 May; 103(10):1419-30. PubMed ID: 10330424 [TBL] [Abstract][Full Text] [Related]
13. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis. Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653 [TBL] [Abstract][Full Text] [Related]
14. Isolation of a 330-kDa glycoprotein from human kidney similar to the Heymann nephritis autoantigen (gp330). Kanalas JJ; Makker SP J Am Soc Nephrol; 1990 Nov; 1(5):792-8. PubMed ID: 2133428 [TBL] [Abstract][Full Text] [Related]
15. A major pathogenic antigen of Heymann nephritis is present exclusively in the renal proximal tubule brush border--studies with a monoclonal antibody against pronase-digested tubular antigen. Tsukada Y; Ono K; Maezawa A; Yano S; Naruse T Clin Exp Immunol; 1994 May; 96(2):303-10. PubMed ID: 8187338 [TBL] [Abstract][Full Text] [Related]
16. Lipoproteins accumulate in immune deposits and are modified by lipid peroxidation in passive Heymann nephritis. Exner M; Susani M; Witztum JL; Hovorka A; Curtiss LK; Spitzauer S; Kerjaschki D Am J Pathol; 1996 Oct; 149(4):1313-20. PubMed ID: 8863678 [TBL] [Abstract][Full Text] [Related]
17. Serum antibodies against megalin (GP330) in patients with autoimmune thyroiditis. MarinĂ² M; Chiovato L; Friedlander JA; Latrofa F; Pinchera A; McCluskey RT J Clin Endocrinol Metab; 1999 Jul; 84(7):2468-74. PubMed ID: 10404822 [TBL] [Abstract][Full Text] [Related]
18. The long-term evolution of immune deposits in passive Heymann nephritis. Soares VA; Almeida DB Braz J Med Biol Res; 1992; 25(2):149-59. PubMed ID: 1339511 [TBL] [Abstract][Full Text] [Related]
19. Endocytic trafficking of megalin/RAP complexes: dissociation of the complexes in late endosomes. Czekay RP; Orlando RA; Woodward L; Lundstrom M; Farquhar MG Mol Biol Cell; 1997 Mar; 8(3):517-32. PubMed ID: 9188102 [TBL] [Abstract][Full Text] [Related]
20. Internalization and recycling of glycoprotein 280 in BN/MSV yolk sac epithelial cells: a model system of relevance to receptor-mediated endocytosis in the renal proximal tubule. Le Panse S; Verroust P; Christensen EI Exp Nephrol; 1997; 5(5):375-83. PubMed ID: 9386973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]